| 0 (0%) | 02-21 18:46 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 101.31 | 1-year : | 118.33 |
| Resists | First : | 86.73 | Second : | 101.31 |
| Pivot price | 83.39  |
|||
| Supports | First : | 78.99 | Second : | 74.19 |
| MAs | MA(5) : | 82.09 |
MA(20) : | 83.01 |
| MA(100) : | 77.25 |
MA(250) : | 54.39 |
|
| MACD | MACD : | 0.5 |
Signal : | 0.8 |
| %K %D | K(14,3) : | 43.9 |
D(3) : | 34.8 |
| RSI | RSI(14): 53.3 |
|||
| 52-week | High : | 86.73 | Low : | 23.95 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ IONS ] has closed above bottom band by 45.9%. Bollinger Bands are 24.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 83.64 - 83.93 | 83.93 - 84.2 |
| Low: | 80.8 - 81.18 | 81.18 - 81.52 |
| Close: | 82.55 - 83.08 | 83.08 - 83.56 |
Sat, 21 Feb 2026
Ionis Pharmaceuticals, Inc. $IONS Shares Sold by Aberdeen Group plc - MarketBeat
Fri, 20 Feb 2026
High-Resolution Spectroscopy of 173Yb+ Ions - AZoOptics
Fri, 20 Feb 2026
Lithium-ion battery fires pose growing threat to homes - investigatetv.com
Fri, 20 Feb 2026
Exploring Analyst Estimates for Ionis Pharmaceuticals (IONS) Q4 Earnings, Beyond Revenue and EPS - Yahoo! Finance Canada
Thu, 19 Feb 2026
Tiny Bubbles Unlock a Powerful New Source of Blue Energy - SciTechDaily
Thu, 19 Feb 2026
Transistor-like MXene membranes enhance ion separation - Phys.org
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 162 (M) |
| Shares Float | 161 (M) |
| Held by Insiders | 0.6 (%) |
| Held by Institutions | 109.2 (%) |
| Shares Short | 13,730 (K) |
| Shares Short P.Month | 16,090 (K) |
| EPS | -1.6 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.83 |
| Profit Margin | -26.6 % |
| Operating Margin | -102.3 % |
| Return on Assets (ttm) | -5.7 % |
| Return on Equity (ttm) | -40.1 % |
| Qtrly Rev. Growth | 17.1 % |
| Gross Profit (p.s.) | 0.45 |
| Sales Per Share | 5.96 |
| EBITDA (p.s.) | -1.65 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -247 (M) |
| Levered Free Cash Flow | -194 (M) |
| PE Ratio | -52.3 |
| PEG Ratio | 0 |
| Price to Book value | 21.65 |
| Price to Sales | 13.92 |
| Price to Cash Flow | -54.53 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|